{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T08:48:48Z","timestamp":1698137328904},"reference-count":26,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":6749,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1990,11]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> Pro\u2010collagen III (PC III) has been proposed as a useful value for diagnosis and follow\u2010up of myeloproliferative disorders. A significant difference is observed between polycythaemia vera (PV) and essential thrombocythaemias (ET) on one hand, and the pure erythrocytoses (PE) on the other hand, but a large overlap makes this test of low diagnostic value. High values are observed in primary and post\u2010PV myelofibrosis, but excessive PC III levels in active PV are not predictive of evolution toward myelofibrosis. PC III level is lower in myelo\u2010suppressed patients (<jats:sup>32<\/jats:sup>P, or hydroxy\u2010urea) than in active cases or in patients treated by phlebotomies. We conclude that PC III measurement is of low diagnostic value for discriminating PV and PE, does not appear to allow short\u2010term prediction of evolution to myelofibrosis, but may be useful to evaluate the role of treatment in delaying progression of PV toward myelofibrosis.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1990.tb00467.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T02:35:40Z","timestamp":1279420540000},"page":"239-243","source":"Crossref","is-referenced-by-count":3,"title":["Clinical significance of serum pro\u2010collagen III in chronic myeloproliferative disorders"],"prefix":"10.1111","volume":"45","author":[{"given":"Yves","family":"Najean","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mich\u00e8le","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odette","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Senechal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean\u2010Paul","family":"Arrago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1979.tb00912.x"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197907053010104"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1979.tb05843.x"},{"key":"e_1_2_1_5_2","first-page":"99","article-title":"The bone marrow in polycythemia vera","volume":"12","author":"Ellis JT","year":"1975","journal-title":"Semin Hemat"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1982.tb00601.x"},{"key":"e_1_2_1_7_2","first-page":"5","article-title":"Diagnosis and classification of polycythemia","volume":"12","author":"Berlin NI","year":"1975","journal-title":"Semin Hemat"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1984.tb01283.x"},{"key":"e_1_2_1_9_2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0308-2261(21)00077-1","article-title":"Definition, clinical features and diagnosis of myelo\u2010fibrosis","volume":"4","author":"Takacsi\u2010Nagy L.","year":"1975","journal-title":"Clinics Haemat"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1979.tb03697.x"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1989.tb07644.x"},{"key":"e_1_2_1_12_2","first-page":"123","article-title":"Int\u00e9r\u00eat clinique du dosage du fragment amino\u2010terminal du pro\u2010collag\u00e8ne III dans les d\u00e9sordres my\u00e9loprolif\u00e9ratifs","volume":"29","author":"Najean Y.","year":"1987","journal-title":"Nouv Rev Fr Hemat"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1986.tb01736.x"},{"key":"e_1_2_1_14_2","first-page":"55","article-title":"Serial determinations of the amino\u2010terminal peptide of type III pro\u2010collagen in severe chronic active hepatitis","volume":"109","author":"Mac\u2010Cullough AJ","year":"1987","journal-title":"J Lab Clin Med"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0174-173X(83)80018-1"},{"key":"e_1_2_1_16_2","first-page":"144","article-title":"Studies in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies","volume":"23","author":"Ellis JT","year":"1986","journal-title":"Seminars Hemat"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830230204"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00598910"},{"key":"e_1_2_1_19_2","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1182\/blood.V59.5.1046.1046","article-title":"Characteristics of bone\u2010marrow fibroblast colony\u2010forming cells and their progeny in patients with myelo\u2010proliferative disorders","volume":"59","author":"Castro\u2010Malaspina H.","year":"1982","journal-title":"Blood"},{"key":"e_1_2_1_20_2","first-page":"938","article-title":"Transforming growth factor b\u00eata","volume":"262","author":"Sporn MB","year":"1989","journal-title":"J Am Med Ass"},{"key":"e_1_2_1_21_2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1182\/blood.V65.4.803.803","article-title":"Myelofibrosis with myeloid metaplasia: pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly","volume":"65","author":"Wolf BC","year":"1985","journal-title":"Blood"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19871215)60:12<2907::AID-CNCR2820601211>3.0.CO;2-B"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(88)90159-8"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1989.tb06309.x"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830180309"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114045"},{"key":"e_1_2_1_27_2","first-page":"705","article-title":"Stimulation of normal rat bone marrow fibroblast proliferation by sera from leukemic Fischer rats","volume":"13","author":"Bauldry SA","year":"1985","journal-title":"Exp Hemat"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1990.tb00467.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1990.tb00467.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T02:06:04Z","timestamp":1698026764000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1990.tb00467.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,11]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1990,11]]}},"alternative-id":["10.1111\/j.1600-0609.1990.tb00467.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1990.tb00467.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,11]]}}}